Dr. Chung-Tsen Hsueh, MD

Dr. Hsueh practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Hsueh's NPI, 1386671907, was assigned on June 27, 2006. Dr. Hsueh graduated from Taipei Medical University in 1986. Dr. Hsueh holds California license C52669.

Dr. Hsueh's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Dr. Hsueh's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Hsueh to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsueh practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hsueh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hsueh is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hsueh is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, neutropenia and prostate cancer among the conditions Dr. Hsueh treats.

CMS data shows 408 Medicare services from Dr. Hsueh across 3 procedure codes in 2024, all of them office visits, for 152 Medicare patients. Medicare paid $27,246 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 152 Medicare patients who saw Dr. Hsueh in 2024. The largest group is 65 to 74, with 71 patients. 74% of them have high blood pressure, and 64% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hsueh's median patient age at 68, with 45% women.

In 2024, Dr. Hsueh wrote 1,143 Medicare Part D claims for 124 patients. 86% of them were for generic drugs. CMS names the drug for 856 of them, across 32 drugs with 11 or more claims each, at $1,371,660 in total drug cost. In 2023, CMS named 837 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Hsueh for performance year 2024, reported as part of a group. Dr. Hsueh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hsueh as offering telehealth.

Dmand AI links 41 papers to Dr. Hsueh, published from 2002 to 2025. 2010 was the busiest year, with 5. The most frequent topics are Tumor Cells, Cultured, RNA, Messenger and Antineoplastic Agents. Dr. Hsueh has published most often in J Hematol Oncol. Dr. Hsueh's most frequent co-authors are James Yu-Chih Tsai, MD, Chien-Shing Chen, MD and Carlos A. Garberoglio, MD.

Dmand AI links Dr. Hsueh to 7 clinical trials. 5 are still active or recruiting. Conditions studied include Colorectal Neoplasms, Colonic Neoplasms and Cystadenocarcinoma, Mucinous. Loma Linda University sponsors the most, 3. Open Payments lists research payments to Dr. Hsueh that name 1 trial.

CMS Open Payments shows 18 general payments to Dr. Hsueh from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Merrimack Pharmaceuticals, Inc. paid the most, $2,396. It also lists 2 research payments totaling $345 from 2016 to 2017, naming 1 clinical trial.

Dmand AI lists 7 awards for Dr. Hsueh, most recently Who’s Who in Medicine and Healthcare - Marquis in 2011.

Dr. Hsueh graduated from Taipei Medical University in 1986. Dr. Hsueh is a member of AACR, ACP, ASCO, ASH, CMA and Chinese American Hematologist and Oncologist Network.

Dr. Hsueh is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.